Government funds universal flu vaccine development

Israel’s BiondVax has just received a 4.87 million shekels grant from Israel’s Chief Scientist, to allow them continue development of their universal influenza vaccine M-001.  The treatment is in advanced trials and the funds will prepare it for commercialization.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *